GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy
Open Access
- 29 September 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 14 (6), 543-552
- https://doi.org/10.1093/humupd/dmn022
Abstract
For preserving fertility in women during chemotherapy, the character of invasive techniques, such as ovarian cryopreservation and other techniques, await further experience. Meanwhile, non-invasive techniques have attempted to minimize the gonadotoxic effect of chemotherapy, by using gonadotrophin-releasing hormone-analogues (GnRH-a) or oral contraceptives (OC). We performed a computerized MEDLINE search to identify articles published on fertility preservation using GnRH-a or OCs. Nine human-controlled studies reported the use of GnRH-a and four reported the use of OCs in parallel to chemotherapy. All nine studies analysing the effect of GnRH-a found lower rates of premature ovarian failure (POF) in patients receiving GnRH-a compared with the controls. Summarizing the studies resulted in 11.1% incidence of POF in patients who received GnRH-a compared with 55.5% incidence in the controls. Evidence using the fertility preserving effect of OC is limited. Two studies showed lower POF rates in OC-treated patients. The summarized data revealed a POF rate of 13.2% in patients who received OCs compared with that of 29.8% in the controls. The published clinical studies provide evidence, but do not prove statistically, that GnRH-a co-treatment reduces gonadotoxicity. Owing to the retrospective and non-randomized nature of most of the studies, definite conclusions concerning the reduction of POF by GnRH-a can still not be unequivocally drawn. As GnRH-a and OC have no serious side effects and as GnRH-a can even reduce chemotherapy-induced complications, such as severe menometrorrhagia, GnRH-a are considered by many clinicians as a clinically useful co-treatment in chemotherapy. The published clinical studies on OC also suggest a possible effect on the reduction of POF under certain conditions.Keywords
This publication has 67 references indexed in Scilit:
- Autocrine and paracrine roles of sphingosine-1-phosphateTrends in Endocrinology & Metabolism, 2007
- Fertility status among women treated for aggressive non-Hodgkin's lymphomaLeukemia & Lymphoma, 2006
- Eggs forever?Differentiation, 2005
- Oocyte Generation in Adult Mammalian Ovaries by Putative Germ Cells in Bone Marrow and Peripheral BloodCell, 2005
- Potential Options for Preservation of Fertility in WomenNew England Journal of Medicine, 2005
- Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonistsFertility and Sterility, 2005
- Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testingHuman Reproduction Update, 2005
- Germline stem cells and follicular renewal in the postnatal mammalian ovaryNature, 2004
- Sphingosine-1-phosphate: an enigmatic signalling lipidNature Reviews Molecular Cell Biology, 2003
- Pregnancy and offspring after adjuvant chemotherapy in breast cancer patientsCancer, 1990